Tonix Pharmaceuticals Reports Second Quarter 2015 Financial Results and Provides Program Update

Go back to Tonix Pharmaceuticals Reports Second Quarter 2015 Financial Results and Provides Program Update

Tonix Pharmaceuticals (TNXP) Misses Q2 EPS by 8c

August 10, 2015 7:24 AM EDT

Tonix Pharmaceuticals (NASDAQ: TNXP) reported Q2 EPS of ($0.73), $0.08 worse than the analyst estimate of ($0.65).

For earnings history and earnings-related data on Tonix Pharmaceuticals (TNXP) click here.

... More